SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: StockDung11/4/2010 8:32:29 PM
   of 5582
 
Homeopathic products 'should carry "no scientific evidence" labels'

04 Nov 10

By Steve Nowottny

Homeopathic products are 'clearly not' medicines and should carry labels warning that there is 'no scientific evidence for homeopathy', the Royal Pharmaceutical Society has said.

Responding to draft guidance on the advertising of homeopathic medicines published by the MHRA this week, the society expressed concerns that the public does not understand the principles on which homeopathy is based, and said there was 'general confusion' about the difference between homeopathic and herbal products.

The society said that labelling on a homepathic product should make it 'very clear' whether the efficacy of products had actually been demonstrated.

Under current rules, products are allowed to carry claims based on the traditional homeopathic use of the product.

But the RPS' chief scientific advisor Jayne Lawrence said: 'Given the lack of clinical and scientific evidence to support homeopathy, the RPSGB does not endorse homeopathy as a form of treament.'

'The society strongly believes that any advertising for any homeopathic product, regardless of its licensing status, needs to include the statements that there is no scientific evidence for homeopathy nor any evidence to support the clinical efficiacy of homeopathic products beyond a placebo effect.'

Last year the sale of homeopathic and herbal products in pharmacies hit the headlines after Paul Bennett, professional standards director at Boots, gave evidence to an inquiry by the House of Commons Science and Technology Committee.

Mr Bennett admitted to MPs that there was 'no evidence' to prove the efficacy of a range of remedies sold by the pharmacy giant, such as arnica and St John's wort, but said there was 'certainly a consumer demand for these products'.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News